KaydedilenlerDerginizi ekleyin

Dergiler / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 11

Nm23 and HER2/neu gene expression and prognostic significance in urothelial carcinomas of the bladder

Remzi Arslan
Fazli Erdogan
Sayfa
1978–1985
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

HER2/neu may be a target for therapy

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: This study aimed to investigate the expressions of Nm23-H1 and HER2/neu in Turkish cases of urothelial carcinomas of bladder and to examine their associations with prognostic parameters.
📊
Temel Bulgular & Veri:Nm23-H1 and HER2/neu expressions have been previously studied in urothelial carcinomas.
💡
Sonuç & Katkı:HER2/neu may be a target for therapy
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: This study aimed to investigate the expressions of Nm23-H1 and HER2/neu in Turkish cases of urothelial carcinomas of bladder and to examine their associations with prognostic parameters. Urothelial carcinoma of the bladder is one of the most prevalent cancers worldwide. Nm23-H1 and HER2/neu expressions have been previously studied in urothelial carcinomas. Despite the availability of many reports in the literature, the prognostic significance of these expressions remains unclear. Materials and Methods: Fifty cases of urothelial carcinoma of the bladder treated with radical cystectomy were retrospectively reviewed. The tumor specimens were evaluated by immunohistochemistry using Nm23-H1 and HER2/neu antibodies. Results: Immunohistochemically, Nm23-H1 and HER2/neu expressions were present in 80% and 18% of cases and associated with pathological stage (p=0.025 and p=0.023, respectively). Conclusion: Both antibodies were noted in patients with advanced stage cancer, which can adversely affect prognosis in infiltrative urothelial carcinomas of the bladder. HER2/neu may be a target for therapy

🔖

Bu Makaleye Atıf Yap

Arslan, R., Erdogan, F. (2022). Nm23 and HER2/neu gene expression and prognostic significance in urothelial carcinomas of the bladder. Annals of Medical Research, Cilt: 28 - Sayı: 11, 1978–1985. https://ajindex.com/articles/446306

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424
  2. Zeegers MP, Kellen E, Buntinx F, et al. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392-401
  3. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66:4-34
  4. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. Eur Urol 2016;70:93-105
  5. Shiina H, Igawa M, Nagami H, et al. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder. Cancer 1996;78:1762-74
  6. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. JNCI 1988;80:200-4
  7. Rosengard AM, Krutzsch HC, Shearn A, et al. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 1989;342:177-80
  8. Hansel DE, Swain E, Dreicer R, et al. HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases. Am J Clin Pathol 2008;130:274-81
  9. El Ochi MR, Oukabli M, Bouaiti E, et al. Expression of human epidermal growth factor receptor 2 in bladder urothelial carcinoma. BMC clinical pathology 2017;17:3
  10. Ceylan O, Ozmen S. Prognostic Significance of HER2 Expression in Gastric Cancer. Black Sea Journal of Health Science 2021;4:52-57 11. Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran pathologic basis of disease, professional edition e-book: Elsevier health sciences 2014
  11. Ceylan O, Karabulut I. Importance of cytokeratin-20 expression in papillary urothelial neoplasia. Cukurova Med J 2020; 45:1326-1332 13. Mhawech-Fauceglia P, Cheney RT, Schwaller J. Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer 2006;106:1205-16
  12. Kadlubar FF, Badawi AF. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett 1995;82:627-32
  13. Lapham RL, Grignon D, Ro JY, editors. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semi